clonidine has been researched along with Cardiomyopathies, Primary in 2 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wootton, DG | 1 |
| De Conca, V | 1 |
| Michetti, P | 1 |
1 trial available for clonidine and Cardiomyopathies, Primary
| Article | Year |
|---|---|
[Clinico-experimental evaluation of a new anti-hypertensive agent 2 (2-6 dichlorophenylamino)-imidazoline chlorhydrate].
Topics: Aged; Cardiomyopathies; Clinical Trials as Topic; Clonidine; Diabetic Angiopathies; Drug Evaluation; | 1974 |
1 other study available for clonidine and Cardiomyopathies, Primary
| Article | Year |
|---|---|
A fatality due to drug synergism.
Topics: Adult; Cardiomyopathies; Clonidine; Death, Sudden; Drug Synergism; Female; Furosemide; Humans; Hypok | 1982 |